Garder ma session ouverte ?
Expiré dans 
La session est expirée
Votre session a expiré. Pour votre sécurité, VWR vous a déconnecté.
Voulez-vous vous connecter à nouveau?

From pipeline to patient: How Ready-to-Use vials can accelerate the drug development process

Webinar

Thursday, 5th October, 2023  
10:00 AM to 11:00 AM CEST (Berlin, Paris, Madrid)

Replay

Ready-to-Use products offered as particulate cleaned, depyrogenated and sterile primary packaging components are experiencing a rapid market adoption. Ready-to-Use vials in particular have the ability to accelerate traditional drug development journeys and support pharmaceutical and biotechnology companies in meeting the growth in demand for personalized medicines and biologics.

In this webinar, DWK Life Sciences has teamed up with Avantor to provide insight on:-

  • The role Ready-to-Use vials can play in improving flexibility, efficiency and patient safety
  • How a strategic partnership between DWK Life Sciences and Stevanato Group has increased the availability of the world’s most widely adopted Ready-to-Use vial standard, Stevanato Group’s EZ-fill® vials
  • How this increased availability benefits the development phase, technology transfer and commercialization of new drugs at early stages
     

For more information, please contact us at webinar@avantorsciences.com.

Presented By:

Dr Felix Brosi   

Dr Felix Brosi
 

Dr. Felix Brosi is Global Head of Product Management at DWK Life Sciences. He has more than six years' experience in pharmaceutical primary packaging in customer consultancy and product management. He holds a PhD in inorganic chemistry from Freie Universität, Berlin and is passionate about cars and coffee.